dehydroepiandrosterone has been researched along with Hyperinsulinism in 33 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Hyperinsulinism: A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Inflammation is involved in the progression of polycystic ovary syndrome." | 5.91 | Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue†. ( Ding, X; Li, G; Li, N; Lin, Y; Ma, Y; Wang, X; Xiong, C; Yang, Y; Yuan, Y; Zhang, Y; Zhang, Z, 2023) |
| "Our results suggest that reactive hyperinsulinemia during OGTT might activate the androgen pathway of adrenal cortex including DHEA production." | 5.32 | The effect of physiologic hyperinsulinemia during an oral glucose tolerance test on the levels of dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) in healthy young adults born with low and with normal birth weight. ( Bardóczy, Z; Bencsik, P; Szathmari, M; Treszl, A; Tulassay, T; Vásárhelyi, B, 2003) |
| "In this study, the effects of DHEA treatment on insulin sensitivity were investigated in genetically obese Zucker rats, an animal model of insulin resistance, using the euglycemic clamp technique." | 5.30 | Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats. ( Kimura, M; Kiuchi, Y; Sekihara, H; Tanaka, S; Yamada, Y; Yamakawa, T, 1998) |
| "These results indicate that acute hyperinsulinemia of 12- to 16-h duration does not increase serum testosterone or DHEA-S concentrations and, indeed, can cause a decline in serum DHEA-S levels in both normal women and the single woman studied with hyperandrogenism, insulin resistance, and acanthosis nigricans." | 5.27 | The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. ( Blackard, WG; Clore, JN; Nestler, JE; Strauss, JF, 1987) |
| " Body weight, retroperitoneal fat depot weight, serum glucose, insulin, and leptin levels, and hepatic lipids were measured." | 3.81 | Sex-related differences in the effects of high-fat diets on DHEA-treated rats. ( Arbo, BD; Cecconello, AL; Hoefel, AL; Kucharski, LC; Marques, CV; Osterkamp, G; Ribeiro, MF; Trapp, M, 2015) |
| " Anthropometric measurements, staging of pubertal maturation, and clinical manifestations of hyperandrogenism were assessed, as well as measurement of serum levels of testosterone, dehydroepiandrosterone sulfate (DHEAS), sex hormone-binding globulin (SHBG), and free androgen index (FAI)." | 3.72 | Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy. ( Abd El-Basset, FZ; El Barbary, NS; El-Khayat, HA; Hakky, SM; Mohamed, MS; Nassef, NM; Tohamy, SM; Tomoum, HY; Zaky, AA, 2004) |
| "The purpose of this study was to determine whether administration of dehydroepiandrosterone (DHEA) protects male rats against the accumulation of body fat the development of insulin resistance with advancing age." | 3.70 | DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats. ( Chen, MM; Han, DH; Hansen, PA; Holloszy, JO, 1998) |
| "The suppression of hyperinsulinism with diazoxide (300 mg/d during 30 days) in a young woman with PCOS and hirsutism, hyperinsulinism and insulinoresistance was followed by a modification of plasma androgens." | 3.69 | [Polycystic ovary and diazoxide. In vivo study]. ( Bercovici, JP; Brettes, JP; Floch, HH; Monguillon, P; Nahoul, K, 1996) |
| "We advance the hypothesis that hyperinsulinemia promotes macrovascular disease in part by reducing serum DHEA and DHEA-sulfate levels and illustrate how this may be the case in two clinical conditions characterized by hyperinsulinemic insulin resistance: aging and obesity." | 2.38 | Dehydroepiandrosterone: the "missing link" between hyperinsulinemia and atherosclerosis? ( Blackard, WG; Clore, JN; Nestler, JE, 1992) |
| "Inflammation is involved in the progression of polycystic ovary syndrome." | 1.91 | Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue†. ( Ding, X; Li, G; Li, N; Lin, Y; Ma, Y; Wang, X; Xiong, C; Yang, Y; Yuan, Y; Zhang, Y; Zhang, Z, 2023) |
| "Our results suggest that reactive hyperinsulinemia during OGTT might activate the androgen pathway of adrenal cortex including DHEA production." | 1.32 | The effect of physiologic hyperinsulinemia during an oral glucose tolerance test on the levels of dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) in healthy young adults born with low and with normal birth weight. ( Bardóczy, Z; Bencsik, P; Szathmari, M; Treszl, A; Tulassay, T; Vásárhelyi, B, 2003) |
| "Despite hyperinsulinemia, the glucose production of db/db mice in the total body and hepatocytes was elevated as compared to their heterozygote littermate C57BL/KsJ-db/+m mice." | 1.32 | Dehydroepiandrosterone decreases elevated hepatic glucose production in C57BL/KsJ-db/db mice. ( Aoki, K; Ito, S; Ito, Y; Mori, Y; Muramatsu, K; Nakamura, S; Satoh, S; Sekihara, H; Taniguchi, H; Yamashita, R, 2004) |
| "On the other hand, hyperandrogenism is associated with certain insulin-resistant conditions with hyperinsulinaemia, including the polycystic ovary syndrome (PCO)." | 1.31 | Two hyperandrogenic adolescent girls with congenital portosystemic shunt. ( Fujisawa, T; Hachiya, M; Hachiya, Y; Hoshino, K; Saji, T; Satoh, M; Yokoya, S, 2001) |
| "Hyperandrogenism was observed in women with upper-body obesity, as evident by significantly elevated free testosterone (P < ." | 1.30 | Hyperinsulinemia and sex hormones in healthy premenopausal women: relative contribution of obesity, obesity type, and duration of obesity. ( Ivandić, A; Jurić, M; Prpić-Krizevac, I; Sucić, M, 1998) |
| "In this study, the effects of DHEA treatment on insulin sensitivity were investigated in genetically obese Zucker rats, an animal model of insulin resistance, using the euglycemic clamp technique." | 1.30 | Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats. ( Kimura, M; Kiuchi, Y; Sekihara, H; Tanaka, S; Yamada, Y; Yamakawa, T, 1998) |
| "The acute effects of hyperinsulinemia on androgen homeostasis and a possible association of androgens to insulin sensitivity, serum lipids and lipoproteins and to lipid oxidation were examined in 19 healthy males (27 +/- 1 yrs, body mass index 24 +/- 1 kg/m2)." | 1.29 | Acute hyperinsulinemia, androgen homeostasis and insulin sensitivity in healthy man. ( Ebeling, P; Koivisto, VA; Seppälä, M; Stenman, UH, 1995) |
| "Insulin resistance and its attendant hyperinsulinemia has been linked with hyperandrogenism." | 1.29 | Serum androgens in hyperinsulinemic Pima Indian and obese Caucasian women and their response to short-term insulin infusion. ( Berkowitz, AS; Bogardus, C; Charles, MA; Nader, S; Saad, MF, 1993) |
| "During the hyperinsulinemia, serum DHEA-S levels fell progressively and were significantly lower than baseline at 4 and 6 h of study (85." | 1.28 | Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms. ( Barlascini, CO; Blackard, WG; Clore, JN; Nestler, JE; Usiskin, KS; Welty, DF, 1989) |
| "Their insulin resistance was significantly greater than that in a control group with comparable obesity." | 1.27 | Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: pediatric perspective and natural history. ( Cavallo, A; Meyer, WJ; Peters, EJ; Prince, MJ; Richards, GE; Smith, ER; Stuart, CA, 1985) |
| "These results indicate that acute hyperinsulinemia of 12- to 16-h duration does not increase serum testosterone or DHEA-S concentrations and, indeed, can cause a decline in serum DHEA-S levels in both normal women and the single woman studied with hyperandrogenism, insulin resistance, and acanthosis nigricans." | 1.27 | The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. ( Blackard, WG; Clore, JN; Nestler, JE; Strauss, JF, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (21.21) | 18.7374 |
| 1990's | 16 (48.48) | 18.2507 |
| 2000's | 7 (21.21) | 29.6817 |
| 2010's | 2 (6.06) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 1 |
| Lin, Y | 1 |
| Li, G | 1 |
| Yuan, Y | 1 |
| Wang, X | 1 |
| Li, N | 1 |
| Xiong, C | 1 |
| Yang, Y | 1 |
| Ma, Y | 1 |
| Zhang, Z | 1 |
| Ding, X | 1 |
| Cecconello, AL | 1 |
| Trapp, M | 1 |
| Hoefel, AL | 1 |
| Marques, CV | 1 |
| Arbo, BD | 1 |
| Osterkamp, G | 1 |
| Kucharski, LC | 1 |
| Ribeiro, MF | 1 |
| Chen, Y | 1 |
| Qiao, J | 1 |
| Yan, LY | 1 |
| Huang, S | 1 |
| Zhao, PL | 1 |
| Yan, J | 1 |
| Shayya, R | 1 |
| Chang, RJ | 1 |
| Vásárhelyi, B | 1 |
| Bencsik, P | 1 |
| Treszl, A | 1 |
| Bardóczy, Z | 1 |
| Tulassay, T | 1 |
| Szathmari, M | 1 |
| Aoki, K | 1 |
| Taniguchi, H | 1 |
| Ito, Y | 1 |
| Satoh, S | 1 |
| Nakamura, S | 1 |
| Muramatsu, K | 1 |
| Yamashita, R | 1 |
| Ito, S | 1 |
| Mori, Y | 1 |
| Sekihara, H | 3 |
| El-Khayat, HA | 1 |
| Abd El-Basset, FZ | 1 |
| Tomoum, HY | 1 |
| Tohamy, SM | 1 |
| Zaky, AA | 1 |
| Mohamed, MS | 1 |
| Hakky, SM | 1 |
| El Barbary, NS | 1 |
| Nassef, NM | 1 |
| Helm, KD | 1 |
| McCartney, CR | 1 |
| Okonkwo, QL | 1 |
| Blank, SK | 1 |
| Barrett, EJ | 1 |
| Marshall, JC | 1 |
| Ebeling, P | 1 |
| Stenman, UH | 1 |
| Seppälä, M | 1 |
| Koivisto, VA | 1 |
| Słowińska-Srzednicka, J | 1 |
| Malczewska, B | 1 |
| Srzednicki, M | 1 |
| Chotkowska, E | 1 |
| Brzezińska, A | 1 |
| Zgliczyński, W | 1 |
| Ossowski, M | 1 |
| Jeske, W | 1 |
| Zgliczyński, S | 1 |
| Sadowski, Z | 1 |
| Hautanen, A | 2 |
| Adlercreutz, H | 2 |
| Nader, S | 1 |
| Charles, MA | 1 |
| Saad, MF | 1 |
| Berkowitz, AS | 1 |
| Bogardus, C | 1 |
| Lasco, A | 1 |
| Cucinotta, D | 1 |
| Gigante, A | 1 |
| Denuzzo, G | 1 |
| Pedulla, M | 1 |
| Trifiletti, A | 1 |
| Frisina, N | 1 |
| Isojärvi, JI | 1 |
| Laatikainen, TJ | 1 |
| Knip, M | 1 |
| Pakarinen, AJ | 1 |
| Juntunen, KT | 1 |
| Myllylä, VV | 1 |
| Moghetti, P | 1 |
| Castello, R | 1 |
| Negri, C | 1 |
| Tosi, F | 1 |
| Spiazzi, GG | 1 |
| Brun, E | 1 |
| Balducci, R | 2 |
| Toscano, V | 2 |
| Muggeo, M | 1 |
| Bercovici, JP | 1 |
| Monguillon, P | 1 |
| Nahoul, K | 1 |
| Floch, HH | 1 |
| Brettes, JP | 1 |
| Ivandić, A | 1 |
| Prpić-Krizevac, I | 1 |
| Sucić, M | 1 |
| Jurić, M | 1 |
| Han, DH | 1 |
| Hansen, PA | 1 |
| Chen, MM | 1 |
| Holloszy, JO | 1 |
| Kimura, M | 2 |
| Tanaka, S | 2 |
| Yamada, Y | 2 |
| Kiuchi, Y | 1 |
| Yamakawa, T | 2 |
| Yamaguchi, Y | 1 |
| Ukawa, K | 1 |
| Ishihara, M | 1 |
| Räikkönen, K | 1 |
| Satoh, M | 1 |
| Yokoya, S | 1 |
| Hachiya, Y | 1 |
| Hachiya, M | 1 |
| Fujisawa, T | 1 |
| Hoshino, K | 1 |
| Saji, T | 1 |
| Stephen, LJ | 1 |
| Kwan, P | 1 |
| Shapiro, D | 1 |
| Dominiczak, M | 1 |
| Brodie, MJ | 1 |
| Nestler, JE | 4 |
| Clore, JN | 4 |
| Blackard, WG | 4 |
| Bianchi, P | 1 |
| Guglielmi, R | 1 |
| Mangiantini, A | 1 |
| Lubrano, C | 1 |
| Sciarra, F | 1 |
| Usiskin, KS | 1 |
| Barlascini, CO | 1 |
| Welty, DF | 1 |
| Richards, GE | 1 |
| Cavallo, A | 1 |
| Meyer, WJ | 1 |
| Prince, MJ | 1 |
| Peters, EJ | 1 |
| Stuart, CA | 1 |
| Smith, ER | 1 |
| Strauss, JF | 1 |
| Alper, MM | 1 |
| Garner, PR | 1 |
| Gansler, TS | 1 |
| Muller, S | 1 |
| Cleary, MP | 1 |
| Gordon, ES | 1 |
| Holzmann, H | 1 |
| Morsches, B | 1 |
| Beyer, J | 1 |
| Wenzel, D | 1 |
| Oertel, GW | 1 |
| Krapp, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Dehydroepiandrosterone on Live Birth Rate in Subfertile Patients With Poor Ovarian Responds[NCT02432248] | 350 participants (Anticipated) | Interventional | 2015-02-28 | Recruiting | |||
| Biologic Effects of DHEA in Humans[NCT00099697] | 56 participants | Interventional | 2001-06-30 | Completed | |||
| Is DHEA Replacement Beneficial?[NCT00182975] | Phase 3 | 142 participants (Actual) | Interventional | 2002-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for dehydroepiandrosterone and Hyperinsulinism
| Article | Year |
|---|---|
Reproductive endocrinology of adolescent polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgens; Anovulation; Anti-Mullerian Hormone; Child; Dehydroepiandrosterone; Fe | 2010 |
Dehydroepiandrosterone: the "missing link" between hyperinsulinemia and atherosclerosis?
Topics: Aging; Animals; Arteriosclerosis; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; Hy | 1992 |
Metabolism and actions of dehydroepiandrosterone in humans.
Topics: Apolipoproteins B; Body Composition; Body Weight; Cholesterol; Dehydroepiandrosterone; Dehydroepiand | 1991 |
Metabolic aspects of obesity.
Topics: Acidosis; Adenosine Triphosphate; Adipose Tissue; Adrenal Cortex Hormones; Alcoholism; Animals; Body | 1970 |
29 other studies available for dehydroepiandrosterone and Hyperinsulinism
| Article | Year |
|---|---|
Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue†.
Topics: Adipose Tissue, White; Animals; Dehydroepiandrosterone; Female; Glucagon-Like Peptide-1 Receptor; Hu | 2023 |
Sex-related differences in the effects of high-fat diets on DHEA-treated rats.
Topics: Animals; Blood Glucose; Body Weight; Dehydroepiandrosterone; Diet, High-Fat; Female; Hyperinsulinism | 2015 |
Selective impairment in glycogen synthase kinase-3 and mitogen-activated protein kinase phosphorylation: comparisons with the hyperandrogenic and the hyperinsulinemic rats.
Topics: Animals; Blood Glucose; Chorionic Gonadotropin; Dehydroepiandrosterone; Estrous Cycle; Extracellular | 2009 |
The effect of physiologic hyperinsulinemia during an oral glucose tolerance test on the levels of dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) in healthy young adults born with low and with normal birth weight.
Topics: Adult; Birth Weight; Blood Glucose; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; | 2003 |
Dehydroepiandrosterone decreases elevated hepatic glucose production in C57BL/KsJ-db/db mice.
Topics: Adjuvants, Immunologic; Animals; Blood Glucose; Body Weight; Cells, Cultured; Dehydroepiandrosterone | 2004 |
Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Dehydroepiandrosterone; Epilepsy; Female; Growth; | 2004 |
Hyperinsulinemia does not acutely enhance adrenal androgen production in women or men.
Topics: Adrenal Glands; Adult; Androgens; Body Mass Index; Dehydroepiandrosterone; Dehydroepiandrosterone Su | 2007 |
Acute hyperinsulinemia, androgen homeostasis and insulin sensitivity in healthy man.
Topics: Acute Disease; Adult; Androgens; C-Peptide; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; | 1995 |
Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease.
Topics: Adult; Coronary Angiography; Coronary Disease; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfat | 1995 |
Hyperinsulinaemia, dyslipidaemia and exaggerated adrenal androgen response to adrenocorticotropin in male smokers.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Adult; Alcohol Drinking; Androstenedione; | 1993 |
Serum androgens in hyperinsulinemic Pima Indian and obese Caucasian women and their response to short-term insulin infusion.
Topics: Adipose Tissue; Adult; Arizona; Body Mass Index; Dehydroepiandrosterone; Dehydroepiandrosterone Sulf | 1993 |
No changes of peripheral insulin resistance in polycystic ovary syndrome after long-term reduction of endogenous androgens with leuprolide.
Topics: Adult; Androgens; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; F | 1995 |
Obesity and endocrine disorders in women taking valproate for epilepsy.
Topics: Adult; Body Weight; Carbamazepine; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Endocrine | 1996 |
Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; 17-Hydroxycorticosteroids; Adolescent; A | 1996 |
[Polycystic ovary and diazoxide. In vivo study].
Topics: Adolescent; Androgens; Dehydroepiandrosterone; Diazoxide; Female; Hirsutism; Humans; Hyperinsulinism | 1996 |
Hyperinsulinemia and sex hormones in healthy premenopausal women: relative contribution of obesity, obesity type, and duration of obesity.
Topics: Adult; Androstenedione; Body Weight; C-Peptide; Dehydroepiandrosterone; Estradiol; Fasting; Female; | 1998 |
DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats.
Topics: Adipose Tissue; Aging; Animals; Body Composition; Body Mass Index; Body Weight; Dehydroepiandrostero | 1998 |
DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats.
Topics: Adipose Tissue; Aging; Animals; Body Composition; Body Mass Index; Body Weight; Dehydroepiandrostero | 1998 |
DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats.
Topics: Adipose Tissue; Aging; Animals; Body Composition; Body Mass Index; Body Weight; Dehydroepiandrostero | 1998 |
DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats.
Topics: Adipose Tissue; Aging; Animals; Body Composition; Body Mass Index; Body Weight; Dehydroepiandrostero | 1998 |
Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats.
Topics: Animals; Body Weight; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Eating; Female; Glucos | 1998 |
Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia.
Topics: Adrenocorticotropic Hormone; Adult; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Diabetes | 1998 |
Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males.
Topics: 17-alpha-Hydroxyprogesterone; Abdomen; Adrenal Cortex; Adult; Body Constitution; Body Mass Index; C- | 1997 |
Two hyperandrogenic adolescent girls with congenital portosystemic shunt.
Topics: Adolescent; Adrenocorticotropic Hormone; Androstenedione; Dehydroepiandrosterone; Female; Glucose To | 2001 |
Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
Topics: Adult; Anticonvulsants; Blood Glucose; Body Mass Index; Comorbidity; Dehydroepiandrosterone; Epileps | 2001 |
Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
Topics: Adolescent; Adult; Androgens; Androstenedione; Dehydroepiandrosterone; Female; Follicle Stimulating | 1992 |
Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms.
Topics: Adult; Androstenedione; Creatinine; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Glucuron | 1989 |
Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: pediatric perspective and natural history.
Topics: Acanthosis Nigricans; Adolescent; Androstenedione; Body Weight; Child; Dehydroepiandrosterone; Femal | 1985 |
The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans.
Topics: Acanthosis Nigricans; Adult; Androgens; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Fema | 1987 |
Elevated serum dehydroepiandrosterone sulfate levels in patients with insulin resistance, hirsutism, and acanthosis nigricans.
Topics: Acanthosis Nigricans; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Follicle Stimu | 1987 |
Chronic administration of dehydroepiandrosterone reduces pancreatic beta-cell hyperplasia and hyperinsulinemia in genetically obese Zucker rats.
Topics: Animals; Blood Glucose; Dehydroepiandrosterone; Female; Hyperinsulinism; Hyperplasia; Insulin; Islet | 1985 |
[Hyperinsulinism and limited glucose-tolerance in psoriasis].
Topics: Administration, Oral; Adolescent; Adult; Biological Transport; Blood Glucose; Dehydroepiandrosterone | 1972 |